drug · antibody
patient view →bafisontamab
Phase 2updated 2mo agoby EpimAb Biotherapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 1 2 (across all indications), with 2 investigational indications.
indications
indications
NSCLC
targets
Epidermal growth factor receptorHepatocyte growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that